Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Effectiveness of Clover Oil (Szygium Aromaticum) and Citraf Oil (Cymbopogon Citratus) as Removal of Culex Sp Mosquito Larms

Budiman , Hamidah , Maharani . Sinergi Kawula Muda. Journal of Health Literacy and Qualitative Research. 2025; 5 (1) : 17-24.
Download PDF
Publication

Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial

Koudou GB, Bjerum CM, Ouattara FA, et al. Elsevier BV. The Lancet Infectious Diseases. 2025;
Download PDF
Publication

Outcomes and cost-effectiveness of an integrated holistic care package on persons affected by podoconiosis, lymphatic filariasis and leprosy and community members in north-western Ethiopia: an implementation research study

Ali O, Mihretu A, Hounsome N, et al. Springer Science and Business Media LLC. BMC Medicine. 2025; 23 (1) : 1-12.
Download PDF
Publication

Global Preventive and Management Strategies and Their Effectiveness in Patients With Secondary Lymphedema: A Scoping Review

Mwesigye V, Atwine D, Munguciada EF, et al. Springer Science and Business Media LLC. Cureus. 2025;
Download PDF
Publication

The psychosocial and emotional burden of lymphatic filariasis: A systematic review

Vásconez-González J, Miño C, Noboa MDL, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2025; 19 (5) : e0013073.
Download PDF
Publication

Antifilarial treatment strategies: a systematic review and network meta-analysis

Albadrani MS, Molla A, Elbadawy HM, et al. Springer Science and Business Media LLC. BMC Infectious Diseases. 2025; 25 (1) : 1-13.
Download PDF
Publication

Impact of mass drug administration of ivermectin and albendazole on transmission of <i>Wuchereria bancrofti</i> lymphatic filariasis from 2001 to 2017 in <scp>Burkina Faso</scp>

Sawadogo A, Zoungrana J, Ouédraogo AG, et al. Wiley. Tropical Medicine &amp; International Health. 2025;
Download PDF
Publication

Potentials of genomics in combating neglected tropical diseases (NDTs) in Africa: a brief review

Kwaga JKP, Tizhe DT, Ogra IO, et al. OU Scientific Route. EUREKA: Life Sciences. 2025;
Practical material

Methods and tools to strengthen lymphatic filariasis (LF) morbidity management and disability prevention (MMDP) services

Toubali E, Brady M, Mensah E, et al. USAID. 2021;
Publication

Beyond business as usual for lymphatic filariasis mass drug administration in hotspot districts

de Souza DK, Sumboh JG, Laryea NA, et al. Oxford University Press (OUP). International Health. 2025;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 4
  • Next page ››
Subscribe to Lymphatic filariasis (Elephantiasis)

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD